Azitra is trading at $0.77, up 6.37%, in line with a broader market rebound as investors responded to stronger-than-expected October jobs data.
- The Nasdaq and S&P 500 were higher.
- No new company-specific announcement for November 6 was identified; the latest company news was its October 29 ATR-04 trial eligibility expansion. Available evidence points to broad-market sentiment rather than a distinct Azitra catalyst, and live-move trading-volume details were unavailable.